Veracyte reported $154.25M in Cash and Equivalent for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Agenus AGEN:US USD 178.67M 29.68M
Agilent A:US USD 1.25B 197M
Anika Therapeutics ANIK:US USD 86.33M 1.45M
Arrowhead Research ARWR:US USD 202.25M 94.24M
Bruker BRKR:US USD 645.5M 19.3M
Exact Sciences EXAS:US USD 64.32M 2.99M
Heron Therapeutics HRTX:US USD 50.44M 1.83M
Illumina ILMN:US USD 2.01B 1.01B
Immunogen IMGN:US USD 275.14M 34.37M
Intrexon XON:US USD 4.86M 4.21M
Karyopharm Therapeutics KPTI:US USD 277.97M 206.62M
Laboratory Of America LH:US USD 430M 20.1M
Ligand Pharmaceuticals LGND:US USD 211.87M 207.75M
Myriad Genetics MYGN:US USD 3.3M 49.6M
Rigel Pharmaceuticals RIGL:US USD 24.46M 5.41M
Roche Holding ROG:VX 4.99B 676M
Sangamo Biosciences SGMO:US USD 100.44M 5.87M
Siemens SIE:GR EUR 10.14B 330M
Thermo Fisher Scientific TMO:US USD 8.52B 5.6B
Veracyte VCYT:US USD 154.25M 15.86M
Waters WAT:US USD 481.39M 37.75M